FutureDx Summit 2026 · For US Diagnostics Companies
Your Beachhead Into the UK and Europe
For a US diagnostics company, the UK is the English-speaking way into Europe, with one national buyer instead of a thousand payers. FutureDx puts 150 plus validated NHS buyers in front of you in two days.
P.S. One trip, one room, one national buyer. Then take the proof to the continent.
Instant download. Your PDF opens as soon as you submit.
The launchpad
Why the UK Is Your Way Into Europe
Of all the ways to cross the Atlantic into healthcare, the UK is the one with the fewest moving parts.
English-Speaking Gateway
Start where there is no language barrier, then expand into Europe.
One Buyer, Not a Thousand Payers
A single national system instead of the US payer patchwork.
A Reference That Travels
NHS validation carries weight with buyers worldwide.
One Trip, a Whole Market
Two days that replace months of remote, cross-time-zone selling.
The difference you will feel
One Payer, Not a Payer Maze
This is the change that surprises US diagnostics teams most. At home you sell coverage plan by plan. Here, there is one national buyer.
Sell It a Hundred Times
Win One National Buyer
For a US company used to selling payer by payer, a single national buyer changes the whole motion. The summit is where you start that one conversation.
The play
Land the UK, Reach Europe
The UK is not just a market. It is the proof point that makes the rest of Europe pick up the phone.
Prove It in the UK
Land NHS reference sites in an English-language market first.
Build European Credibility
UK adoption is a proof point the continent respects.
Expand Across Europe
Move into the EU from a position of evidence, not a standing start.
A general pattern, not a promise. Your path depends on your product, evidence, and follow-up, but it starts with the right first market.
Coming from the US
What Changes When You Cross Over
Four shifts to plan for. None of them are dealbreakers, and the brief and the team help you with each.
On regulation we point you to the right advisers. We do not provide regulatory advice ourselves.
Worth the flight
Make the Transatlantic Trip Count
A trip across the Atlantic is a real commitment. A pre-booked diary is what makes it pay.
Two Days, Not Two Quarters
One trip that replaces months of remote outreach.
Pre-Arranged, Not Hoped For
Your diary is booked before you board the plane.
Face to Face Wins
Relationships that email across time zones never builds.
The room
The Buyers Waiting Across the Atlantic
You only cross an ocean for the right people. Here is who is in the room.
Delegate Seniority
The Whole Market, in One Visit
Instead of a string of transatlantic trips to meet trusts one at a time, you meet senior, validated buyers from across the UK in two days. For a US company, that is the most efficient way to test the UK and Europe. Reach them through the 1:1 meetings programme or a sponsorship package.
The brief
The US Expansion Brief
Everything to Plan Your UK and Europe Push
- The audience profile and NHS buyer mix
- Which package fits a transatlantic expansion plan
- How the pre-arranged meeting model works
- A high-level note on UK and EU market entry
- Pricing and what is included
Instant download. Your PDF opens as soon as you submit.
Questions
What a US Company Asks
Why start with the UK and not go straight to the EU?
The UK is the English-speaking entry point to Europe, with one national health system rather than 27 separate markets. Landing the NHS gives you a credible reference that travels, so the UK is usually the lowest-friction first step before wider European expansion.
We are FDA-cleared. What about UK and EU regulation?
FDA clearance does not transfer directly. The UK uses its own UKCA marking alongside continued recognition of CE marking for many medical devices, with timelines that have shifted since Brexit. The expansion brief covers the current position at a high level and we can point you to the right advisers. We do not give regulatory advice ourselves.
How is selling to the NHS different from US payers?
In the US you sell payer by payer, plus IDNs and GPOs. The NHS is a single national health system, organised across four UK nations but procuring on a national-scale model. The motion is less about plan-by-plan coverage and more about a value and budget case, which the summit is built to start.
Is the trip worth it from the US?
Two days of pre-arranged meetings with 150 plus validated senior buyers replaces months of remote, cross-time-zone outreach. For a transatlantic trip, a packed and pre-booked diary is what makes it pay, which is exactly what FutureDx provides. See the cost per lead analysis.
Who will we meet?
Senior diagnostics professionals from across the UK, more than 60% at VP level and above, every one validated as a decision-maker or procurement influencer before they register. You can tell the team which trusts, regions, and roles you most want to reach.
How many meetings can we get?
It depends on your package: pre-arranged meetings range from 6 with Gold to 15 with Headline, or up to 20 with the standalone 1:1 Meetings programme. Each is a confirmed conversation with a validated NHS buyer.
Is the inaugural edition a safe bet for a US company?
It is a low-commitment one. The room is capped and validated, your spend is tied to confirmed meetings rather than the gamble of footfall, and you find out whether the UK and Europe are worth a bigger investment without first building an overseas team.
When and where is FutureDx Summit 2026 held?
FutureDx Summit 2026 runs across two days on 27 and 28 October 2026 in London, UK, with a drinks reception on Day 1.
Cross the Atlantic
Plant Your Flag in the UK
Send your details and a senior member of the team replies with the expansion brief and builds a plan around the buyers and regions you most want to reach.
- Validated NHS buyers, no overseas team required
- Pre-arranged meetings across two days
- A reply from a person, not an autoresponder
P.S. Based in the UK or Europe instead? See UK companies, German companies, or all packages.